Literature DB >> 24282658

A verrucous plaque on the lower leg.

Sarina Drusinsky1, Karan Lal, Faisal Hamid, Viktoryia Kazlouskaya.   

Abstract

Entities:  

Year:  2013        PMID: 24282658      PMCID: PMC3839826          DOI: 10.5826/dpc.0303a04

Source DB:  PubMed          Journal:  Dermatol Pract Concept        ISSN: 2160-9381


× No keyword cloud information.

Quiz case

A 52-year-old male patient from South Africa presented with a lesion on his lower left leg extending from the ankle to just below the knee that has been present for twenty years. The lesion first developed as a verrucous nodule close to the lateral part of the ankle and gradually enlarged, involving the entire lower leg. Clinical examination revealed a verrucous plaque with an elevated border and central areas of atrophy and scar formation. The patient was otherwise healthy, in an excellent physical profile (Figure 1). He had no associated leg pain, abdominal pain, or any history of recurrent fevers. There was no history of systemic disease, and physical examination with CBC was within normal limits. A biopsy was obtained from the verrucous plaque. Histopathologic findings revealed epidermal hyperplasia and papillomatosis. Granulomas were noted in the dermis showing central suppuration and necrosis (Figure 2). A marked plasma cell infiltrate was also evident. Copper colored muriform bodies were revealed in some granulomas (Figure 3).
Figure 1.

Verrucous plaque on the lower leg. [Copyright: ©2013 Kazlouskaya et al.]

Figure 2.

Suppurative granulomas with neutrophils, histiocytes and plasma cells. [Copyright: ©2013 Kazlouskaya et al.]

Figure 3.

Copper colored muriform bodies. [Copyright: ©2013 Kazlouskaya et al.]

Answer

Given the histopathological and clinical information, a diagnosis of was made.

Discussion

Chromoblastomycosis is a fungal infection usually found in tropical and subtropical climates [1]. The causative agents for this infection include but are not limited to dematiaceous fungi Fonsecaea pedrosoi, Fonsecaea compacta, Rhinocladiella aquaspersa, Cladophialophora, and Phialophora verrucosa. This infection was first described in Brazil by Pedroso de Morales. It usually develops in adolescents working with soil in rural environments. Chromoblastomycosis is seen predominantly in males [1]. Poverty and absence of proper footwear are the main factors involved in the etiology and development of the infection. Fungal organisms are often implanted in the skin as a result of mild trauma. Microorganisms transform into filamentous forms within tissues. The infection tends to be chronic and may be present several years. The lesions are usually confined to the lower legs, but cases have been reported of the infection located on the face, scalp, groin and arms. Mucous membranes are not affected. Different clinical presentations of chromoblastomycosis are described: nodular, tumor-like, verrucous hypertrophic plaques, scaly papules, and as cicatricial atrophic lesions [1]. Verrucous plaques are the most common clinical presentation. More than one type of lesion may be present in one patient, given the polymorphic clinical nature of the infection. Pruritus may accompany early lesions [2]. Clinically the diagnosis is not specific and may be misdiagnosed with other infectious conditions such as Mycobacteria infections and sporotrichosis, as well as neoplastic conditions (squamous cell carcinoma, basal cell carcinoma and keratoacanthoma). Typical copper colored muriform bodies can be identified by direct microscopic examination via a KOH preparation. Dermatopathological examination of the lesions reveals epidermal hyperplasia with suppuration granulomas. Fungi are also typically seen on biopsy. Culture of the scrapings on the Sabouraud agar aids in identifying the causal organism. Treatment is region specific but often includes systemic antifugal medications such as terbinafine (200–250 mg/day), itraconazole (100–400 mg/day), fluconazole (100–400 mg/day), and/or ketoconazole (200–400 mg/day). Amphotericin B is less effective and is usually used in combination therapy. This patient was placed on 400 mg itraconazole therapy for two months and clinical improvement was seen in several months (Figure 4). The infection is difficult to treat and it may be refractory to antifungal therapy. Relapses are common. Treatment is usually prolonged and is performed until negative cultures are obtained [3]. Surgical excision or cryotherapy may be performed in cases of small lesions. Heat has been described to help in healing of the lesions. Portable pocket heaters showed to be effective in killing pathologic fungi, with temperatures higher than 420° C [3].
Figure 4.

Atrophic scar formation within healing lesions. [Copyright: ©2013 Kazlouskaya et al.]

Chromoblastomycosis infection rarely has systemic complications and this is the reason why patients refer to their physician in late stages of the infection. Squamous cell carcinoma may rarely arise in chromoblastomycosis lesions [4]. A case of osseous infection due to overlying chromoblastomycosis has also been described [5]. Lymphedema and elephantiasis may develop as a result of lymphatic spread and obstruction [6]. Cases of internal organ involvement are extremely rare in immunocompetent individuals.
  6 in total

1.  Chromoblastomycosis.

Authors:  Edoardo Torres-Guerrero; Rafael Isa-Isa; Mariel Isa; Roberto Arenas
Journal:  Clin Dermatol       Date:  2012 Jul-Aug       Impact factor: 3.541

Review 2.  Chromoblastomycosis.

Authors:  Rubén López Martínez; Luis Javier Méndez Tovar
Journal:  Clin Dermatol       Date:  2007 Mar-Apr       Impact factor: 3.541

3.  Chromoblastomycosis associated with a lethal squamous cell carcinoma.

Authors:  Edoardo Torres; Javier Gil Beristain; Zahide Lievanos; Roberto Arenas
Journal:  An Bras Dermatol       Date:  2010 Mar-Apr       Impact factor: 1.896

Review 4.  Chromoblastomycosis: an overview of clinical manifestations, diagnosis and treatment.

Authors:  Flavio Queiroz-Telles; Phillippe Esterre; Maigualida Perez-Blanco; Roxana G Vitale; Claudio Guedes Salgado; Alexandro Bonifaz
Journal:  Med Mycol       Date:  2008-12-09       Impact factor: 4.076

5.  Chromoblastomycosis with underlying osteolytic lesion.

Authors:  Nand Lal Sharma; Vikas C Sharma; Vikram Mahajan; Vinay Shanker; Sandip Sarin
Journal:  Mycoses       Date:  2007-11       Impact factor: 4.377

6.  Genital elephantiasis as a complication of chromoblastomycosis: A diagnosis overlooked.

Authors:  Nidhi Sharma; Y S Marfatia
Journal:  Indian J Sex Transm Dis AIDS       Date:  2009-01
  6 in total
  1 in total

1.  A Clinico-Mycological Study on Suspected Cases of Chromoblastomycosis: Challenges in Diagnosis and Management.

Authors:  Hirak Jyoti Raj; Banashree Majumdar; Atul Jain; Prasanta Kumar Maiti; Gobinda Chatterjee
Journal:  J Clin Diagn Res       Date:  2015-12-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.